Structure Therapeutics to Participate in the Jefferies London Healthcare Conference

Rhea-AI Summary

Structure Therapeutics (NASDAQ: GPCR), a clinical-stage biopharmaceutical company focused on developing oral small molecule therapeutics for metabolic and cardiopulmonary diseases, has announced its participation in the Jefferies London Healthcare Conference. The event will take place from November 19-21, 2024, in London, UK.

The company's management will deliver a presentation and participate in a fireside chat on Wednesday, November 20 at 8:00 a.m. GMT, while also hosting one-on-one meetings. A live webcast will be available on the company's website, with a replay accessible for 90 days following the event.

SAN FRANCISCO, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and cardiopulmonary diseases, today announced that management will participate in a presentation and fireside chat, and host one-on-one meetings at the Jefferies London Healthcare Conference being held November 19-21, 2024, in London, UK.

Jefferies London Healthcare Conference

	Format:	Presentation and fireside chat
	Date/time:	Wednesday, November 20 at 8:00 a.m. GMT

The live and archived webcast will be accessible from the company’s website at https://ir.structuretx.com/events-presentations/events and a replay will be available for 90 days.

About Structure Therapeutics 
Structure Therapeutics is a science-driven clinical-stage biopharmaceutical company focused on discovering and developing innovative oral small molecule treatments for chronic metabolic and cardiopulmonary conditions with significant unmet medical needs. Utilizing its next generation structure-based drug discovery platform, the Company has established a robust GPCR-targeted pipeline, featuring multiple wholly-owned proprietary clinical-stage small molecule compounds designed to surpass the scalability limitations of traditional biologic and peptide therapies and be accessible to more patients around the world. For additional information, please visit www.structuretx.com.

Investors:
Danielle Keatley
Structure Therapeutics Inc.
ir@structuretx.com

Media:
Dan Budwick
1AB
Dan@1abmedia.com

FAQ

When is Structure Therapeutics (GPCR) presenting at the Jefferies London Healthcare Conference 2024?

Structure Therapeutics will present on Wednesday, November 20, 2024, at 8:00 a.m. GMT during the Jefferies London Healthcare Conference.

How can I watch Structure Therapeutics' (GPCR) presentation at the Jefferies Conference?

The presentation can be viewed via live webcast on Structure Therapeutics' website at ir.structuretx.com/events-presentations/events, with replay available for 90 days.

What type of meetings will Structure Therapeutics (GPCR) host at the Jefferies London Healthcare Conference?

Structure Therapeutics will host one-on-one meetings, deliver a presentation, and participate in a fireside chat at the conference.

What is the duration of the Jefferies London Healthcare Conference where Structure Therapeutics (GPCR) is participating?

The Jefferies London Healthcare Conference runs from November 19-21, 2024, in London, UK.